History
  • No items yet
midpage
Marentette v. Abbott Labs., Inc.
886 F.3d 112
2d Cir.
2018
Read the full case

Background

  • Three parents sued Abbott Laboratories alleging Similac "Organic" infant formula was falsely labeled because it contained ingredients allegedly prohibited by the Organic Foods Production Act (OFPA); they sought consumer-protection, breach-of-warranty, and unjust-enrichment claims under NY and CA law.
  • Plaintiffs bought Similac Advance Organic between 2012–2014; packaging displayed the word "organic" and the USDA Organic seal.
  • Plaintiffs alleged the formula contained 16 (allegedly prohibited) ingredients and relied on the label in purchasing; they did not allege Abbott deceived its certifying agent or that the certifying plan was improperly certified.
  • Abbott moved to dismiss, arguing state-law claims were preempted by the OFPA (conflict/obstacle preemption); the district court granted dismissal on conflict-preemption grounds and denied leave to amend.
  • The Second Circuit invited the USDA to file an amicus brief; USDA explained certifying agents review and approve ingredients and plans, and that certification is intended to be coextensive with OFPA compliance except in cases of improper certification or post‑certification changes.
  • The court considered the OFPA’s structure (national standards, certification by accredited agents, enforcement and appeal scheme) and concluded consumer suits that effectively challenge certification decisions would undermine Congress’s objectives.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether state-law consumer claims challenging an organic label are preempted by OFPA (conflict/obstacle preemption) Parents: claims vindicate federal standard (§6504(1)); certification reviews process not product, so state suits enforcing organic standard complement federal law Abbott: allowing state-law challenges to a certified organic label would conflict with and obstruct the OFPA’s national certification scheme Held: Preempted — Plaintiffs’ claims effectively challenge the federal certification decision and thus pose an obstacle to Congress’s objectives
Whether certification and OFPA compliance are separable (i.e., can state courts relitigate product organic status) Parents: certification ≠ proof of compliance; courts can decide product compliance under state law Abbott: certification is coextensive with compliance; litigation would undermine uniformity and the certifier’s role Held: Certification is intended to encompass ingredients and inputs; plaintiffs’ theory would require courts to second‑guess certification, so preempted
Relevance of OFPA’s express preemption clause to implied conflict preemption Parents: express preemption provision (state schemes barred unless approved) shows Congress didn’t intend broader preemption Abbott: express clause does not bar ordinary conflict-preemption analysis Held: Existence of express preemption does not preclude obstacle preemption; ordinary preemption principles apply
Adequacy of federal enforcement/remedy scheme vs. private suits Parents: lack of private remedy and limited USDA recall power justify consumer suits Abbott: Congress created exclusive administrative enforcement and appeal mechanisms to ensure national uniformity Held: The statutory enforcement/appeal scheme and OFPA purposes support preemption of consumer challenges to certification decisions

Key Cases Cited

  • In re Aurora Dairy Corp. Organic Milk Mktg. & Sales Practices Litig., 621 F.3d 781 (8th Cir. 2010) (held state-law challenges that effectively contest OFPA certification are preempted)
  • In re Methyl Tertiary Butyl Ether (MTBE) Prod. Liab. Litig., 725 F.3d 65 (2d Cir. 2013) (explains conflict preemption framework and purpose-driven inquiry)
  • Arizona v. United States, 567 U.S. 387 (2012) (discusses express preemption clause not displacing ordinary conflict-preemption principles)
  • Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996) (presumption against preemption in areas traditionally regulated by states)
  • Wyeth v. Levine, 555 U.S. 555 (2009) (same; courts start with presumption against federal preemption)
  • Geier v. Am. Honda Motor Co., 529 U.S. 861 (2000) (conflict preemption analysis and effects of express preemption language)
  • Bates v. Dow Agrosciences LLC, 544 U.S. 431 (2005) (addresses interplay of express preemption clauses and conflict preemption)
  • Hines v. Davidowitz, 312 U.S. 52 (1941) (formulation of obstacle preemption doctrine)
Read the full case

Case Details

Case Name: Marentette v. Abbott Labs., Inc.
Court Name: Court of Appeals for the Second Circuit
Date Published: Mar 23, 2018
Citation: 886 F.3d 112
Docket Number: Docket No. 17-62-cv; August Term, 2017
Court Abbreviation: 2d Cir.